O’Connell, M., Kamp, A., Mertz, S., Kuhrt, M., Zidanyue Yang, L., Erkanli, A., … Kram, B. (2026). 512: OPIOID REQUIREMENTS IN VENTILATED PATIENTS TAKING BUPRENORPHINE/NALOXONE PRIOR TO ADMISSION. In Critical Care Medicine (Vol. 54). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.ccm.0001184044.15581.02

O’Connell, Molly, Ashley Kamp, Sean Mertz, Michelle Kuhrt, Lexie Zidanyue Yang, Alaattin Erkanli, Christopher Cox, and Bridgette Kram. “512: OPIOID REQUIREMENTS IN VENTILATED PATIENTS TAKING BUPRENORPHINE/NALOXONE PRIOR TO ADMISSION.” In Critical Care Medicine, Vol. 54. Ovid Technologies (Wolters Kluwer Health), 2026. https://doi.org/10.1097/01.ccm.0001184044.15581.02.

O’Connell M, Kamp A, Mertz S, Kuhrt M, Zidanyue Yang L, Erkanli A, et al. 512: OPIOID REQUIREMENTS IN VENTILATED PATIENTS TAKING BUPRENORPHINE/NALOXONE PRIOR TO ADMISSION. In: Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2026.

O’Connell, Molly, et al. “512: OPIOID REQUIREMENTS IN VENTILATED PATIENTS TAKING BUPRENORPHINE/NALOXONE PRIOR TO ADMISSION.” Critical Care Medicine, vol. 54, no. 3S, Ovid Technologies (Wolters Kluwer Health), 2026. Crossref, doi:10.1097/01.ccm.0001184044.15581.02.

O’Connell M, Kamp A, Mertz S, Kuhrt M, Zidanyue Yang L, Erkanli A, Cox C, Kram B. 512: OPIOID REQUIREMENTS IN VENTILATED PATIENTS TAKING BUPRENORPHINE/NALOXONE PRIOR TO ADMISSION. Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2026.